Holtzman receives grant to develop drug treatment for respiratory diseases

Michael J. Holtzman, MD, the Selma and Herman Seldin Professor of Medicine and director of the Division of Pulmonary & Critical Care Medicine at the School of Medicine, has received a 2020 Scholar-Innovator Award from the Harrington Discovery Institute at University Hospitals in Cleveland. He is one of six physician-scientists from the U.S. and Canada selected for a grant supporting drug development. The grant provides a total of $100,000 in funding for a new drug to correct stem cell reprogramming in the lining of the airway, in an effort to improve treatment of respiratory diseases.

Leave a Comment

Comments and respectful dialogue are encouraged, but content will be moderated. Please, no personal attacks, obscenity or profanity, selling of commercial products, or endorsements of political candidates or positions. We reserve the right to remove any inappropriate comments. We also cannot address individual medical concerns or provide medical advice in this forum.